EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›NIU

NIU

Niu Technologies

Next earnings Aug 10, 2026 · consensus $1.28 EPS, $1.60B rev

Sell
$1.98
▲ +1.54%
$1.98▼ -45.00%
over 1Y
L $1.95EODHDH $5.56
Today+1.5%
1W-3.4%
1M-15.7%
3M-27.7%
YTD-36.9%
1Y-45.0%
OverviewFinancialsValuationQualityFilings
Rating
Sell
Quality
C
Valuation
Fair value
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy

Revenue grew 36.7% YoY; but unprofitable (net margin -0.9%).

Revenue (FY2025) $616M · FY2025

Niu Technologies shows $616M in FY2025 revenue (+36.7% YoY), a -0.9% net margin, and -4.4% ROE.

Supporting the case: revenue grew 36.7% YoY.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$581M$459M$373M$450M$616M
Gross profit$128M$97.1M$80.4M$68.3M$121M
Operating income$39.6M-$12.9M-$44.7M-$34.3M-$12.6M
Net income$35.4M-$7.17M-$38.3M-$26.5M-$5.63M
Diluted EPS$0.22-$0.05-$0.24-$0.17-$0.04
Net margin6.1%-1.6%-10.3%-5.9%-0.9%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$23.1M
EV / EBITDA7.1
EV / Sales0.0
EV / FCF0.9
P / FCF6.2
PEG (trailing)—
Earnings yield-3.6%
FCF yield16.2%

Quality & risk

ROIC (est.)-7.7%
Free cash flow$25.1M
Total debt—
Net cash$132M
Altman Z-Score1.31 distress
Piotroski F-Score5/8

Capital returns

Buyback yield0.4%
Dividend yield (est.)—
Shareholder yield0.4%
Shares Δ YoY+0.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Recent filings

all on EDGAR ↗
SCHEDULE 13D/AFiling2026-06-26open ↗SCHEDULE 13D/AFiling2026-06-12open ↗6-KPeriod ending 2026-05-182026-05-18open ↗20-FPeriod ending 2025-12-312026-04-17open ↗6-KPeriod ending 2026-04-062026-04-06open ↗6-KPeriod ending 2026-03-182026-03-18open ↗4Period ending 2026-03-152026-03-17open ↗144Filing2026-03-16open ↗SCHEDULE 13D/AFiling2026-03-13open ↗3Period ending 2026-03-062026-03-06open ↗3Period ending 2026-03-062026-03-06open ↗3Period ending 2026-03-022026-03-04open ↗

Quality score

C
ValueGrowthProfitHealthMom.
ValueA+
GrowthA+
ProfitabilityF
Financial healthC
MomentumF
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗Liabilities below 2× equity
1.9552-week5.56
Revenue
$616M
+36.7% YoY
Net margin
-0.9%
ROE
-4.4%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$616M+36.7%
Net income-$5.63M+78.7%
Gross profit$121M+76.5%
Operating income-$12.6M+63.2%
Diluted EPS-$0.04+76.5%
Cash & equivalents$132M+53.2%
Total assets$422M+17.8%
Total liabilities$292M+26.9%
Stockholders' equity$129M+1.4%
Gross: 19.6%Op.: -2.0%L/E: 2.26x

Frequently asked

Is Niu Technologies (NIU) a buy?
NIU currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 36.7% YoY; but unprofitable (net margin -0.9%).
What is Niu Technologies's quality score?
NIU scores 57.00136018183111/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001744781, latest SCHEDULE 13D/A filed 2026-06-26) · EODHD · as of 6/30/2026, 11:26:42 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-03-16
Zhou Fion Wenjuan
Chief Financial Officer
Sell22.1K @ $3.48$77.0K
2026-03-15
Zhou Fion Wenjuan
Chief Financial Officer
Exercise45.0K

Vs tracked universe

compare →

1192 tracked peers · median

EDGAR Score57 vs 67
Revenue growth36.7% vs 7.5%
Net margin-0.9% vs 10.0%
Return on equity-4.4% vs 12.0%
P/E— vs 25.7